Physician profile
Angela Ng
NPI 1265768394
$438.73
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.45 · 2022: $52.54 · 2023: $150 · 2024: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Sanofi Pasteur INC. | $79.96 | 2022-2024 | |
| Glaxosmithkline, LLC. | $77.75 | 2019-2023 | Shingrix, Bexsero, Arexvy |
| Pfizer INC. | $41.67 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $28.89 | 2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Gilead Sciences, INC. | $25.00 | 2024 | Epclusa |
| Exact Sciences Corporation | $20.44 | 2023 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $20.02 | 2023 | Heplisav-B |
| Lilly USA, LLC | $20.00 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.